Search
Codexis Inc
CDXSAdd to Watchlist
1.400USD
-0.080-5.41%
Close 07-31 16:00（ET）Quotes delayed by 15 min
150.59MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Codexis Inc is 8.00, ranking 171 out of 385 in the Biotechnology & Medical Research industry. The average price target is 7.00, with a high of 11.00 and a low of 2.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
6.583
Target Price
+347.85%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Codexis Inc
CDXS
7
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Codexis Inc's expected revenue for the next quarter?
Codexis Inc's expected revenue is 14.35M.
What is Codexis Inc's price target?
Analysts forecast that Codexis Inc's price target is USD 7.00, with the highest forecast at USD 11.00 and the lowest forecast at USD 2.00.
How have Codexis IncCDXS's recent earnings per share performed?
The market expectation was USD -0.10, while Codexis IncCDXS's earnings per share (EPS) for the previous quarter was USD 0.11. EPS for the next quarter is expected at USD -0.14.
What is the analyst rating for Codexis Inc?
Based on the ratings of Codexis Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.